This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Philippe Yves-Remy Simon, Vita Api. Active years: 2021.
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2021
Title: Henri Oreal: Innovator in Cancer and Neurodegenerative Disorder Treatments
Introduction
Henri Oreal is a notable inventor based in Le Revest les Eaux, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for cancer and neurodegenerative disorders. His innovative work has led to the creation of a patent that showcases his expertise and dedication to improving medical outcomes.
Latest Patents
Henri Oreal holds a patent for "Proteasome inhibiting β-lactam prodrugs useful for the treatment of cancer and neurodegenerative disorders." This invention relates to proteasome inhibiting β-lactam compounds that are beneficial in treating these serious health conditions. The patent also includes pharmaceutical compositions and extended release formulations of these compounds, highlighting their medical uses in combating cancer and neurodegenerative disorders.
Career Highlights
Throughout his career, Henri Oreal has worked with various companies, including Philippe Yves-Remy Simon and Vita Api. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Henri Oreal has collaborated with notable individuals in his field, including Didier Siri and Anouk Siri. These partnerships have further enhanced his work and expanded the impact of his inventions.
Conclusion
Henri Oreal's contributions to the treatment of cancer and neurodegenerative disorders through his innovative patents demonstrate his commitment to advancing medical science. His work continues to inspire future research and development in the pharmaceutical industry.